Figure 4.
Evolution of CO and PVR values at 3, 6, and 12 months in patients with PH
Group A - newly diagnosed overt hyperthyroidism; Group B - recurrent hyperthyroidism; Group C - subclinical hyperthyroidism; PVR - pulmonary vascular resistance; CO - cardiac output; the Friedman test followed by a post-hoc analysis with Wilcoxon signed-rank test was conducted with a Bonferroni correction applied resulting in a significance level set at p<0.008